NanoViricides Completes Licensing for Coronavirus Field which Includes Current COVID-19 Drug Development
NanoViricides is developing oral and pediatric drugs to fight COVID-19 designed to be effective against most variants.
Tweet this
NanoViricides is currently working on taking its two COVID-19 lead drug candidates, namely, NV-CoV-2- and NV-CoV-2-R, into…
